Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

